Skip to content

YOLOAdvisorShares Pure Cannabis ETF

Grow my money7y track recordRanked #1,324 of 3,055 in this goal

Seeks long-term capital appreciation.

By AdvisorShares · Launched 2019

Annual Cost

0.51%

#2,900 of 6,040 · average

Fund Size

$36M

#4,091 of 6,040 · small

Return (1Y)

-5.3%

Track Record

7 years

#1,876 of 6,040 · established

Performance

Total-return NAV · USD
Growth of $10,000
$9,421-5.8%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Active selection

Focus

Biotech & Genomics

Holdings

By weight

Concentration

Top 10 holdings = 99.4% of fundconcentrated

AdvisorShares Trust
47.2%
Village Farms Inte
18.5%
High Tide Inc
9.7%
Charlottes Web Holdings Inc
5.2%
Cronos Group Inc
4.3%
Organigram Global Inc.
4.0%
SNDL Inc
3.7%
DREY INST PREF GOV MM-MDSVXX
3.2%
Aurora Cannabis Inc
1.8%
Rubicon Organics Inc
1.7%

Asset allocation

Stocks
84.3%
Cash
12.9%
Other
2.4%
Bonds
0.5%

By sector

Healthcare
83.6%
Consumer Defensive
16.4%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
68.6%High

Year-on-year price swings

Max drawdown
-94.7%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.09Below average
Sortino (3Y)
0.15Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks long-term capital appreciation.
Strategy
Actively manages an ETF investing primarily in mid- and small-cap companies deriving at least 50% of revenue from marijuana and hemp. Concentrates at least 25% in the pharmaceuticals, biotechnology & life sciences sector within health care, focusing on growth opportunities.
Inception date
April 17, 2019
Fund family
AdvisorShares

Next steps

Save YOLO to compare it with other funds, or start building a portfolio.

Data updated on 2026-09-18